HomeHealthcare and Life Sciences North America Allergy Rhinitis Drugs Market

North America Allergy Rhinitis Drugs Market Size, Share, Growth, and Industry Analysis, Type (Antihistamines, Corticosteroids, Decongestants), Application (OTC, Prescription, Hospital), Regional Insights and Forecast to 2034

Report Code: SMI2836PUB | Last Updated : 05 August, 2026 | Base Year : 2025 | Historical Data : 2022-2024 | Region : North America | Format : PDF, Excel | Number of Pages : 140 | Author : Jenny Burkett

Table of Contents

  1. Executive Summary
    1. Introduction
  2. Market Introduction
    1. Market Definition
    2. Scope of the Study
    3. Market Structure
  3. Research Methodology
    1. Primary Research
    2. Research Methodology
    3. Assumptions & Exclusions
    4. Secondary Data Sources
  4. Market Factor Analysis
    1. Value Chain Analysis: North America Allergy Rhinitis Drugs Market
    2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Dynamics
    1. Drivers
    2. Restraints
    3. Opportunities
  6. Recent Trends Analysis
  7. Impact of COVID-19 on North America Allergy Rhinitis Drugs Market
    1. Pre and Post Covid -19 Market Scenario Analysis
    2. Market Recovery Timeline and Challenge
    3. Measures Taken by Top Players
  8. Regulatory Landscape
  9. North America Allergy Rhinitis Drugs Market, Type
    1. Introduction
      1. Market Size and Forecast, Type
    2. Antihistamines
      1. Market Size and Forecast, By Region
    3. Corticosteroids
      1. Market Size and Forecast, By Region
    4. Decongestants
      1. Market Size and Forecast, By Region
  10. North America Allergy Rhinitis Drugs Market, Application
    1. Introduction
      1. Market Size and Forecast, Application
    2. OTC
      1. Market Size and Forecast, By Region
    3. Prescription
      1. Market Size and Forecast, By Region
    4. Hospital
      1. Market Size and Forecast, By Region
  11. Regional Overview
    1. Introduction
      1. Market Size and Forecast
    2. North America
      1. Market Size and Forecast
        1. Type
          1. Antihistamines
            1. Corticosteroids
              1. Decongestants
              2. Application
                1. OTC
                  1. Prescription
                    1. Hospital
                  2. U.S.
                    1. Type
                      1. Antihistamines
                        1. Corticosteroids
                          1. Decongestants
                          2. Application
                            1. OTC
                              1. Prescription
                                1. Hospital
                              2. Canada
                          3. Competitive Landscape, 2025
                            1. Introduction
                            2. North America Allergy Rhinitis Drugs Market Share Analysis, 2025 (%)
                              1. Market Share Analysis, 2025
                              2. Competition Ranking, 2025
                              3. Key Developments & Growth Strategies
                                1. Merger & Acquisition
                                2. Product Launch
                                3. Expansion
                              4. Consolidated SWOT Analysis of Key Players
                          4. Company Profile
                            1. Johnson & Johnson
                              1. Business Overview
                              2. Financial Data
                              3. Key Product domains
                              4. Recent Developments
                            2. GlaxoSmithKline
                            3. Sanofi
                            4. Pfizer
                            5. Bayer AG
                            6. Novartis
                            7. Teva Pharmaceuticals
                            8. Merck & Co.
                            9. AstraZeneca
                            10. Boehringer Ingelheim
                            11. AbbVie
                            12. Takeda Pharmaceutical
                            13. Mylan N.V.
                            14. CSL Behring